Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 14.47 CNY -4.43% Market Closed
Market Cap: 21.6B CNY
Have any thoughts about
Tasly Pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is 19.81 CNY. Compared to the current market price of 14.47 CNY, Tasly Pharmaceutical Group Co Ltd is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
19.81 CNY
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Tasly Pharmaceutical Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Tasly Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Tasly Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Tasly Pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of Tasly Pharmaceutical Group Co Ltd.

What unique competitive advantages
does Tasly Pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does Tasly Pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Tasly Pharmaceutical Group Co Ltd.

Provide P/S
for Tasly Pharmaceutical Group Co Ltd.

Provide P/E
for Tasly Pharmaceutical Group Co Ltd.

Provide P/OCF
for Tasly Pharmaceutical Group Co Ltd.

Provide P/FCFE
for Tasly Pharmaceutical Group Co Ltd.

Provide P/B
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/S
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/GP
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/EBIT
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/OCF
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/FCFF
for Tasly Pharmaceutical Group Co Ltd.

Provide EV/IC
for Tasly Pharmaceutical Group Co Ltd.

Show me price targets
for Tasly Pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for Tasly Pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for Tasly Pharmaceutical Group Co Ltd?

What are the Net Income projections
for Tasly Pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for Tasly Pharmaceutical Group Co Ltd?

What are the EPS projections
for Tasly Pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for Tasly Pharmaceutical Group Co Ltd?

What are the EBIT projections
for Tasly Pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for Tasly Pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for Tasly Pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Tasly Pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Tasly Pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Tasly Pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of Tasly Pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Tasly Pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of Tasly Pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Tasly Pharmaceutical Group Co Ltd.

Provide ROE
for Tasly Pharmaceutical Group Co Ltd.

Provide ROA
for Tasly Pharmaceutical Group Co Ltd.

Provide ROIC
for Tasly Pharmaceutical Group Co Ltd.

Provide ROCE
for Tasly Pharmaceutical Group Co Ltd.

Provide Gross Margin
for Tasly Pharmaceutical Group Co Ltd.

Provide Operating Margin
for Tasly Pharmaceutical Group Co Ltd.

Provide Net Margin
for Tasly Pharmaceutical Group Co Ltd.

Provide FCF Margin
for Tasly Pharmaceutical Group Co Ltd.

Show all solvency ratios
for Tasly Pharmaceutical Group Co Ltd.

Provide D/E Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide D/A Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide Quick Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide Current Ratio
for Tasly Pharmaceutical Group Co Ltd.

Provide Cash Ratio
for Tasly Pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Tasly Pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Tasly Pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of Tasly Pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Tasly Pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tasly Pharmaceutical Group Co Ltd

Current Assets 9.8B
Cash & Short-Term Investments 4.8B
Receivables 2.1B
Other Current Assets 2.9B
Non-Current Assets 7.8B
Long-Term Investments 1.9B
PP&E 3.7B
Intangibles 2.1B
Other Non-Current Assets 64.8m
Current Liabilities 3.3B
Accounts Payable 498m
Accrued Liabilities 138.1m
Short-Term Debt 1.9B
Other Current Liabilities 718.3m
Non-Current Liabilities 1.8B
Long-Term Debt 1.3B
Other Non-Current Liabilities 467m
Efficiency

Earnings Waterfall
Tasly Pharmaceutical Group Co Ltd

Revenue
8.7B CNY
Cost of Revenue
-2.9B CNY
Gross Profit
5.7B CNY
Operating Expenses
-4.2B CNY
Operating Income
1.5B CNY
Other Expenses
-498.7m CNY
Net Income
1B CNY

Free Cash Flow Analysis
Tasly Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tasly Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
57/100
Profitability
Score

Tasly Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tasly Pharmaceutical Group Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
73/100
Solvency
Score

Tasly Pharmaceutical Group Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tasly Pharmaceutical Group Co Ltd

Wall Street analysts forecast Tasly Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 17.54 CNY with a low forecast of 15.45 CNY and a high forecast of 20.54 CNY.

Lowest
Price Target
15.45 CNY
7% Upside
Average
Price Target
17.54 CNY
21% Upside
Highest
Price Target
20.54 CNY
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Tasly Pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tasly Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

21.6B CNY

Dividend Yield

0%

Description

Tasly Pharmaceutical Group Co., Ltd. engages in the development, manufacture and distribution of pharmaceutical products. The company is headquartered in Tianjin, Tianjin and currently employs 9,437 full-time employees. The company went IPO on 2002-08-23. The firm's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The firm's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The firm mainly distributes its products in the domestic market.

Contact

TIANJIN
Tianjin
(Tasly Modern Traditional Chinese Medicine City), No. 2, Pujihe East Road, Beichen District
+862226736999
www.taslypharma.com

IPO

2002-08-23

Employees

9 437

Officers

GM & Director
Mr. Jing Su
CFO & Head of Accounting
Ms. Jie Wei
Secretary & VP
Mr. Yu Jie
Deputy GM & Employee Representative of the Supervisory Board
Mr. Jin Yong Cai
Deputy GM & Vice Chairman of the Supervisory Board
Mr. Hongwei Liu
Deputy GM & Supervisor
Mr. Shunnan Zhang

See Also

Discover More
What is the Intrinsic Value of one Tasly Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is 19.81 CNY.

Is Tasly Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 14.47 CNY, Tasly Pharmaceutical Group Co Ltd is Undervalued by 27%.

Back to Top